Epidemiological characteristics of an urban plague epidemic in Madagascar, August-November, 2017: an outbreak report
- PMID:30930106
- PMCID: PMC6483974
- DOI: 10.1016/S1473-3099(18)30730-8
Epidemiological characteristics of an urban plague epidemic in Madagascar, August-November, 2017: an outbreak report
Abstract
Background: Madagascar accounts for 75% of global plague cases reported to WHO, with an annual incidence of 200-700 suspected cases (mainly bubonic plague). In 2017, a pneumonic plague epidemic of unusual size occurred. The extent of this epidemic provides a unique opportunity to better understand the epidemiology of pneumonic plagues, particularly in urban settings.
Methods: Clinically suspected plague cases were notified to the Central Laboratory for Plague at Institut Pasteur de Madagascar (Antananarivo, Madagascar), where biological samples were tested. Based on cases recorded between Aug 1, and Nov 26, 2017, we assessed the epidemiological characteristics of this epidemic. Cases were classified as suspected, probable, or confirmed based on the results of three types of diagnostic tests (rapid diagnostic test, molecular methods, and culture) according to 2006 WHO recommendations.
Findings: 2414 clinically suspected plague cases were reported, including 1878 (78%) pneumonic plague cases, 395 (16%) bubonic plague cases, one (<1%) septicaemic case, and 140 (6%) cases with unspecified clinical form. 386 (21%) of 1878 notified pneumonic plague cases were probable and 32 (2%) were confirmed. 73 (18%) of 395 notified bubonic plague cases were probable and 66 (17%) were confirmed. The case fatality ratio was higher among confirmed cases (eight [25%] of 32 cases) than probable (27 [8%] of 360 cases) or suspected pneumonic plague cases (74 [5%] of 1358 cases) and a similar trend was seen for bubonic plague cases (16 [24%] of 66 confirmed cases, four [6%] of 68 probable cases, and six [2%] of 243 suspected cases). 351 (84%) of 418 confirmed or probable pneumonic plague cases were concentrated in Antananarivo, the capital city, and Toamasina, the main seaport. All 50 isolated Yersinia pestis strains were susceptible to the tested antibiotics.
Interpretation: This predominantly urban plague epidemic was characterised by a large number of notifications in two major urban areas and an unusually high proportion of pneumonic forms, with only 23% having one or more positive laboratory tests. Lessons about clinical and biological diagnosis, case definition, surveillance, and the logistical management of the response identified in this epidemic are crucial to improve the response to future plague outbreaks.
Funding: US Agency for International Development, WHO, Institut Pasteur, US Department of Health and Human Services, Laboratoire d'Excellence Integrative Biology of Emerging Infectious Diseases, Models of Infectious Disease Agent Study of the National Institute of General Medical Sciences, AXA Research Fund, and the INCEPTION programme.
Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. Published by Elsevier Ltd.. All rights reserved.
Figures



Comment in
- Epidemics of plague past, present, and future.Mead P.Mead P.Lancet Infect Dis. 2019 May;19(5):459-460. doi: 10.1016/S1473-3099(18)30794-1. Epub 2019 Mar 28.Lancet Infect Dis. 2019.PMID:30930105No abstract available.
Similar articles
- Multiple Introductions of Yersinia pestis during Urban Pneumonic Plague Epidemic, Madagascar, 2017.Andrianaivoarimanana V, Savin C, Birdsell DN, Vogler AJ, Le Guern AS, Rahajandraibe S, Brémont S, Rahelinirina S, Sahl JW, Ramasindrazana B, Rakotonanahary RJL, Rakotomanana F, Randremanana R, Maheriniaina V, Razafimbia V, Kwasiborski A, Balière C, Ratsitorahina M, Baril L, Keim P, Caro V, Rasolofo V, Spiegel A, Pizarro-Cerda J, Wagner DM, Rajerison M.Andrianaivoarimanana V, et al.Emerg Infect Dis. 2024 Feb;30(2):289-298. doi: 10.3201/eid3002.230759.Emerg Infect Dis. 2024.PMID:38270131Free PMC article.
- [The plague in Madagascar: epidemiologic data from 1989 to 1995 and the national control program].Champetier de Ribes G, Rasoamanana B, Randriambelosoa J, Rakoto LJ, Rabescn D, Chanteau S.Champetier de Ribes G, et al.Sante. 1997 Jan-Feb;7(1):53-60.Sante. 1997.PMID:9172878French.
- Epidemiologic features of four successive annual outbreaks of bubonic plague in Mahajanga, Madagascar.Boisier P, Rahalison L, Rasolomaharo M, Ratsitorahina M, Mahafaly M, Razafimahefa M, Duplantier JM, Ratsifasoamanana L, Chanteau S.Boisier P, et al.Emerg Infect Dis. 2002 Mar;8(3):311-6. doi: 10.3201/eid0803.010250.Emerg Infect Dis. 2002.PMID:11927030Free PMC article.
- The rise of pneumonic plague in Madagascar: current plague outbreak breaks usual seasonal mould.Rabaan AA, Al-Ahmed SH, Alsuliman SA, Aldrazi FA, Alfouzan WA, Haque S.Rabaan AA, et al.J Med Microbiol. 2019 Mar;68(3):292-302. doi: 10.1099/jmm.0.000915. Epub 2019 Jan 11.J Med Microbiol. 2019.PMID:30632956Review.
- Review of genotyping methods for Yersinia pestis in Madagascar.Randriantseheno LN, Andrianaivoarimanana V, Pizarro-Cerdá J, Wagner DM, Rajerison M.Randriantseheno LN, et al.PLoS Negl Trop Dis. 2024 Jun 27;18(6):e0012252. doi: 10.1371/journal.pntd.0012252. eCollection 2024 Jun.PLoS Negl Trop Dis. 2024.PMID:38935608Free PMC article.Review.
Cited by
- Human plague: An old scourge that needs new answers.Vallès X, Stenseth NC, Demeure C, Horby P, Mead PS, Cabanillas O, Ratsitorahina M, Rajerison M, Andrianaivoarimanana V, Ramasindrazana B, Pizarro-Cerda J, Scholz HC, Girod R, Hinnebusch BJ, Vigan-Womas I, Fontanet A, Wagner DM, Telfer S, Yazdanpanah Y, Tortosa P, Carrara G, Deuve J, Belmain SR, D'Ortenzio E, Baril L.Vallès X, et al.PLoS Negl Trop Dis. 2020 Aug 27;14(8):e0008251. doi: 10.1371/journal.pntd.0008251. eCollection 2020 Aug.PLoS Negl Trop Dis. 2020.PMID:32853251Free PMC article.Review.
- Rodent control to fight plague: field assessment of methods based on rat density reduction.Rahelinirina S, Scobie K, Ramasindrazana B, Andrianaivoarimanana V, Rasoamalala F, Randriantseheno LN, Rakotoniaina JS, Gorgé O, Lambin X, Valade E, Telfer S, Rajerison M.Rahelinirina S, et al.Integr Zool. 2021 Nov;16(6):868-885. doi: 10.1111/1749-4877.12529. Epub 2021 Mar 30.Integr Zool. 2021.PMID:33694282Free PMC article.
- Overview ofYersinia pestis Metallophores: Yersiniabactin and Yersinopine.Chaaban T, Mohsen Y, Ezzeddine Z, Ghssein G.Chaaban T, et al.Biology (Basel). 2023 Apr 14;12(4):598. doi: 10.3390/biology12040598.Biology (Basel). 2023.PMID:37106798Free PMC article.Review.
- Characterization of two affinity matured Anti-Yersinia pestis F1 human antibodies with medical countermeasure potential.Velappan N, Biryukov SS, Rill NO, Klimko CP, Rosario-Acevedo R, Shoe JL, Hunter M, Dankmeyer JL, Fetterer DP, Bedinger D, Phipps ME, Watt AJ, Abergel RJ, Dichosa A, Kozimor SA, Cote CK, Lillo AM.Velappan N, et al.PLoS One. 2024 Jul 2;19(7):e0305034. doi: 10.1371/journal.pone.0305034. eCollection 2024.PLoS One. 2024.PMID:38954719Free PMC article.
- Symbiosis of a lytic bacteriophage andYersinia pestis and characteristics of plague inMarmota himalayana.Lyu D, Duan Q, Duan R, Qin S, Zheng X, Lu X, Bukai A, Zhang P, Han H, He Z, Sha H, Wu D, Xiao M, Jing H, Wang X.Lyu D, et al.Appl Environ Microbiol. 2024 Aug 21;90(8):e0099524. doi: 10.1128/aem.00995-24. Epub 2024 Jul 18.Appl Environ Microbiol. 2024.PMID:39023266Free PMC article.
References
- Kool JL. Risk of person-to-person transmission of pneumonic plague. Clin Infect Dis. 2005;40:1166–1172. - PubMed
- Plague around the world, 2010–2015. Wkly Epidemiol Rec. 2016;91:89–93. - PubMed
- Duplantier JM, Duchemin JB, Chanteau S, Carniel E. From the recent lessons of the Malagasy foci towards a global understanding of the factors involved in plague reemergence. Vet Res. 2005;36:437–453. - PubMed
- Migliani R, Chanteau S, Rahalison L. Epidemiological trends for human plague in Madagascar during the second half of the 20th century: a survey of 20 900 notified cases. Trop Med Int Health. 2006;11:1228–1237. - PubMed
Publication types
MeSH terms
Related information
LinkOut - more resources
Full Text Sources
Medical